4.7 Article

The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases

Journal

NATURE PROTOCOLS
Volume 11, Issue 11, Pages 2233-2242

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2016.120

Keywords

-

Funding

  1. EU Joint Program-Neurodegenerative Disease Research (JPND-DEMTEST (Biomarker-based diagnosis of rapid progressive dementias-optimization of diagnostic protocols) [01ED1201A]
  2. Robert Koch Institute through Federal Ministry of Health [1369341]
  3. Intramural Research Program of the NIAID
  4. NHMRC Practitioner Fellowship [APP1005816]
  5. Australian National Creutzfeldt-Jakob Disease Registry (ANCJDR) - Commonwealth Department of Health
  6. Grants-in-Aid for Scientific Research [26305030, 15H04269] Funding Source: KAKEN

Ask authors/readers for more resources

The development and adaption of in vitro misfolded protein amplification systems has been a major innovation in the detection of abnormally folded prion protein scrapie (PrPsc) in human brain and cerebrospinal fluid (CSF) samples. Herein, we describe a fast and efficient protein amplification technique, real-time quaking-induced conversion (RT-QuIC), for the detection of a PrPsc seed in human brain and CSF. In contrast to other in vitro misfolded protein amplification assays-such as protein misfolding cyclic amplification (PMCA)-which are based on sonication, the RT-QuIC technique is based on prion seed-induced misfolding and aggregation of recombinant prion protein substrate, accelerated by alternating cycles of shaking and rest in fluorescence plate readers. A single RT-QuIC assay typically analyzes up to 32 samples in triplicate, using a 96-well-plate format. From sample preparation to analysis of results, the protocol takes similar to 87 h to complete. In addition to diagnostics, this technique has substantial generic analytical applications, including drug screening, prion strain discrimination, biohazard screening (e.g., to reduce transmission risk related to prion diseases) and the study of protein misfolding; in addition, it can potentially be used for the investigation of other protein misfolding diseases such as Alzheimer's and Parkinson's disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available